应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02552 华领医药-B
已收盘 04-09 16:08:13
3.580
-0.070
-1.92%
最高
3.710
最低
3.550
成交量
258.00万
今开
3.670
昨收
3.650
日振幅
4.38%
总市值
37.84亿
流通市值
37.84亿
总股本
10.57亿
成交额
931.08万
换手率
0.24%
流通股本
10.57亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
华领医药-B更新3月股份变动月报表,股本维持稳定
公告速递 · 16:43
华领医药-B更新3月股份变动月报表,股本维持稳定
华领医药(02552)2025年报观:从首迎年度盈利,探寻GKA龙头的长期增长逻辑
智通财经 · 03-27
华领医药(02552)2025年报观:从首迎年度盈利,探寻GKA龙头的长期增长逻辑
华领医药-B早盘大涨超14% 2025年实现创纪录盈利
新浪港股 · 03-27
华领医药-B早盘大涨超14% 2025年实现创纪录盈利
港股异动 | 生物医药股普涨,基石药业-B涨超13%,华领医药涨超11%
老虎资讯综合 · 03-27
港股异动 | 生物医药股普涨,基石药业-B涨超13%,华领医药涨超11%
异动解读 | 华领医药-B盘中大涨5.14%,2025年度业绩实现历史性突破
异动解读 · 03-27
异动解读 | 华领医药-B盘中大涨5.14%,2025年度业绩实现历史性突破
华领医药(02552)2025年度业绩:华堂宁®销量超400万盒 盈利实现历史性突破
智通财经 · 03-27
华领医药(02552)2025年度业绩:华堂宁®销量超400万盒 盈利实现历史性突破
华领医药-B(02552)委任欧阳丽妮为公司秘书
智通财经 · 03-26
华领医药-B(02552)委任欧阳丽妮为公司秘书
每日卖空追踪 | 华领医药-B 03月12日卖空量成交4000股,卖空比例为0.27%
市场透视 · 03-12
每日卖空追踪 | 华领医药-B 03月12日卖空量成交4000股,卖空比例为0.27%
每日卖空追踪 | 华领医药-B 03月11日卖空量成交7.15万股,卖空比例为2.93%
市场透视 · 03-11
每日卖空追踪 | 华领医药-B 03月11日卖空量成交7.15万股,卖空比例为2.93%
华领医药-B03月11日遭主力抛售52.1万元
市场透视 · 03-11
华领医药-B03月11日遭主力抛售52.1万元
华领医药-B盘中异动 早盘大幅拉升5.16%报3.260港元
市场透视 · 03-10
华领医药-B盘中异动 早盘大幅拉升5.16%报3.260港元
每日卖空追踪 | 华领医药-B 03月09日卖空量成交2.95万股,卖空比例为1.81%
市场透视 · 03-09
每日卖空追踪 | 华领医药-B 03月09日卖空量成交2.95万股,卖空比例为1.81%
华领医药-B盘中异动 早盘急速下跌5.10%
市场透视 · 03-09
华领医药-B盘中异动 早盘急速下跌5.10%
华领医药-B(02552)2月股份变动月报:股本维持稳定
公告速递 · 03-05
华领医药-B(02552)2月股份变动月报:股本维持稳定
每日卖空追踪 | 华领医药-B 03月05日卖空量成交33万股,卖空比例为9.13%
市场透视 · 03-05
每日卖空追踪 | 华领医药-B 03月05日卖空量成交33万股,卖空比例为9.13%
华领医药-B03月05日获主力加仓30.9万元
市场透视 · 03-05
华领医药-B03月05日获主力加仓30.9万元
华领医药-B盘中涨近10% 核心产品华领片近日在香港获批上市
智通财经 · 03-05
华领医药-B盘中涨近10% 核心产品华领片近日在香港获批上市
核心产品华领片®于香港获批上市,华领医药-B(02552)开启全球化新征程
智通财经 · 03-04
核心产品华领片®于香港获批上市,华领医药-B(02552)开启全球化新征程
华领医药-B(02552):多格列艾汀在香港获批上市,用于治疗成人2型糖尿病
智通财经 · 03-03
华领医药-B(02552):多格列艾汀在香港获批上市,用于治疗成人2型糖尿病
每日卖空追踪 | 华领医药-B 03月02日卖空量成交21.75万股,卖空比例为7.96%
市场透视 · 03-02
每日卖空追踪 | 华领医药-B 03月02日卖空量成交21.75万股,卖空比例为7.96%
加载更多
公司概况
公司名称:
华领医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
华领医药是一家主要从事用于治疗2型糖尿病的口服新药的开发及商业化的投资控股公司。该公司还从事华堂宁产品的商业化。该公司的主要产品管线Dorzagliatin或HMS5552是一种葡萄糖激酶激活剂或GKA,旨在通过恢复2型糖尿病患者的血糖稳态平衡来控制糖尿病的渐进性退行性特性。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02552","market":"HK","secType":"STK","nameCN":"华领医药-B","latestPrice":3.58,"timestamp":1775722093006,"preClose":3.65,"halted":0,"volume":2580000,"delay":0,"changeRate":-0.019178082191780778,"floatShares":1057000000,"shares":1057000000,"eps":1.2610384624425102,"marketStatus":"已收盘","change":-0.07,"latestTime":"04-09 16:08:13","open":3.67,"high":3.71,"low":3.55,"amount":9310755,"amplitude":0.043836,"askPrice":3.58,"askSize":18000,"bidPrice":3.56,"bidSize":110500,"shortable":3,"etf":0,"ttmEps":1.3286759799735175,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775784600000},"marketStatusCode":5,"adr":0,"listingDate":1536854400000,"exchange":"SEHK","adjPreClose":3.65,"openAndCloseTimeList":[[1775698200000,1775707200000],[1775710800000,1775721600000]],"volumeRatio":0.453673,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02552","defaultTab":"news","newsList":[{"id":"1150565203","title":"华领医药-B更新3月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1150565203","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150565203?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:43","pubTimestamp":1775724230,"startTime":"0","endTime":"0","summary":"华领医药-B(02552)于2026年4月9日公布了截至2026年3月31日的股份变动月报表。报告显示,公司注册股本仍为2,000,000,000股,每股面值0.001美元,对应注册股本总额2,000,000美元,与上月保持一致。\n报告期内,公司已发行股份总数保持在1,056,605,016股,未出现新增发行或回购,亦无库存股相关变动。截至3月31日,股份期权方面发生了100,000股的失效;本月底期权余量由79,139,669股减少至79,039,669股,但并未导致新增股份发行或股本变动。\n公司表示,已遵守包括香港联交所《上市规则》在内的各项法律和监管规定。该公告由公司秘书欧阳丽妮签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622438848","title":"华领医药(02552)2025年报观:从首迎年度盈利,探寻GKA龙头的长期增长逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2622438848","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622438848?lang=zh_cn&edition=full","pubTime":"2026-03-27 15:00","pubTimestamp":1774594800,"startTime":"0","endTime":"0","summary":"截至2025年末,华堂宁已通过3000多家医院、社区卫生中心、药房和线上渠道惠及超50万名患者,商业化体系的成功得到充分验证。值得关注的是,作为全球首创GKA药物的研发企业,华领医药的领跑优势不仅在于创新产品,更在于对“商业确定性”的持续构建,2025年的两大关键进展,进一步强化了其在GKA赛道的龙头地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","02552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622816348","title":"华领医药-B早盘大涨超14% 2025年实现创纪录盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2622816348","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622816348?lang=zh_cn&edition=full","pubTime":"2026-03-27 10:07","pubTimestamp":1774577220,"startTime":"0","endTime":"0","summary":" 华领医药-B早盘大涨超14%,截至发稿,股价上涨14.15%,现报3.55港元,成交额1761.08万港元。 华领医药公布2025年度业绩。报告期内,产品销量达401.1万盒,同比增长91%;净销售额达4.929亿元,同比增长93%。 公司2025年实现创纪录盈利,税前盈利达11.064亿元;现金余额稳健,截至年末达 10.923亿元,为持续运营发展奠定坚实基础;毛利率提升至56.9%,销售开支占比从59.9%优化至33.6%,盈利能力显著增强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-03-27/doc-inhskwcy5418407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02552","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169861203","title":"港股异动 | 生物医药股普涨,基石药业-B涨超13%,华领医药涨超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169861203","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169861203?lang=zh_cn&edition=full","pubTime":"2026-03-27 09:57","pubTimestamp":1774576637,"startTime":"0","endTime":"0","summary":"3月27日,生物医药股普涨,$基石药业-B(02616)$涨超13%,华领医药涨超11%,$开拓药业(09939)$、$来凯医药(02105)$、先瑞达医疗等多股涨超5%","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK1161","BK1191","BK4581","BK1574","02552","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115917126","title":"异动解读 | 华领医药-B盘中大涨5.14%,2025年度业绩实现历史性突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1115917126","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115917126?lang=zh_cn&edition=full","pubTime":"2026-03-27 09:37","pubTimestamp":1774575455,"startTime":"0","endTime":"0","summary":"华领医药-B今日盘中股价大涨5.14%,引起了市场的广泛关注。消息面上,公司公布了截至2025年12月31日止年度的经审核综合业绩。报告显示,其全球首创糖尿病新药华堂宁商业化进程全面提速,销量达401.1万盒,同比增长91%;净销售额达4.929亿元,同比增长93%。此外,公司在知识产权保护、海外市场拓展及新适应症研发方面均取得关键进展。例如,多格列艾汀在中国获得专利期限补偿,新增五年市场独占权,并在香港获批上市。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622608890","title":"华领医药(02552)2025年度业绩:华堂宁®销量超400万盒 盈利实现历史性突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2622608890","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622608890?lang=zh_cn&edition=full","pubTime":"2026-03-27 08:07","pubTimestamp":1774570071,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华领医药 公布截至2025年12月31日止年度经审核的综合业绩。报告期内,公司核心产品、全球首创糖尿病新药、葡萄糖激酶激活剂华堂宁商业化进程全面提速,研发管线持续丰富,财务表现实现历史性突破,成功迈入盈利新阶段。公司预计将于2026年提交多格列艾汀用于MODY-2患者的IND申请。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"华领医药(02552)2025年度业绩:华堂宁®销量超400万盒 盈利实现历史性突破","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02552","BK1191"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622583727","title":"华领医药-B(02552)委任欧阳丽妮为公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2622583727","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622583727?lang=zh_cn&edition=full","pubTime":"2026-03-26 16:34","pubTimestamp":1774514093,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华领医药-B(02552)发布公告,袁颕欣女士(袁女士)已辞任本公司公司秘书及不再担任根据香港联合交易所有限公司证券上市规则第 3.05条所规定的本公司授权代表,均自2026年3月26日起生效。在袁女士辞任后,董事会欣然宣布委任欧阳丽妮女士(欧阳女士)为本公司公司秘书及上市规则规定的第3.05条所规定授权代表,均自2026年3月26日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02552","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618803161","title":"每日卖空追踪 | 华领医药-B 03月12日卖空量成交4000股,卖空比例为0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618803161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618803161?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304232,"startTime":"0","endTime":"0","summary":"华领医药-B北京时间03月12日,跌1.54%,卖空量成交4000股,较上一交易日减少97.29%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163436a4637500&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163436a4637500&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02552","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618691908","title":"每日卖空追踪 | 华领医药-B 03月11日卖空量成交7.15万股,卖空比例为2.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618691908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618691908?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217831,"startTime":"0","endTime":"0","summary":"华领医药-B北京时间03月11日,跌2.69%,卖空量成交7.15万股,较上一交易日减少75.43%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163430a460b70a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163430a460b70a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02552","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618590865","title":"华领医药-B03月11日遭主力抛售52.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618590865","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618590865?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:15","pubTimestamp":1773216928,"startTime":"0","endTime":"0","summary":"03月11日, 华领医药-B股价跌2.69%,报收3.25元,成交金额800.3万元,换手率0.23%,振幅3.29%,量比0.38。华领医药-B今日主力资金净流出52.1万元,连续3日净流出,上一交易日主力净流出394.8万元。该股近5个交易日上涨14.44%,主力资金累计净流出191.4万元;近20日主力资金累计净流入700.1万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161657a6b786a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161657a6b786a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02552","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618932389","title":"华领医药-B盘中异动 早盘大幅拉升5.16%报3.260港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618932389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618932389?lang=zh_cn&edition=full","pubTime":"2026-03-10 10:08","pubTimestamp":1773108491,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘10时08分,华领医药-B股票出现异动,股价快速拉升5.16%。截至发稿,该股报3.260港元/股,成交量105.6万股,换手率0.10%,振幅5.16%。资金方面,该股资金流入229.26万港元,流出113.987万港元。华领医药-B股票所在的生物技术行业中,整体涨幅为4.64%。其相关个股中,百奥赛图-B、康方生物、来凯医药-B涨幅较大,振幅较大的相关个股有百奥赛图-B、轩竹生物-B、科济药业-B,振幅分别为16.68%、13.65%、13.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310100811a45cfcc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310100811a45cfcc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","02552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618967414","title":"每日卖空追踪 | 华领医药-B 03月09日卖空量成交2.95万股,卖空比例为1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618967414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618967414?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045032,"startTime":"0","endTime":"0","summary":"华领医药-B北京时间03月09日,跌1.27%,卖空量成交2.95万股,较上一交易日减少94.41%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163429a45ae85b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163429a45ae85b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02552","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618485606","title":"华领医药-B盘中异动 早盘急速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618485606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618485606?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:59","pubTimestamp":1773021588,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时59分,华领医药-B股票出现异动,股价快速下挫5.10%。截至发稿,该股报2.980港元/股,成交量44.85万股,换手率0.04%,振幅3.82%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。华领医药-B股票所在的生物技术行业中,整体跌幅为4.99%。华领医药-B公司简介:华领医药是一家主要从事用于治疗2型糖尿病的口服新药的开发及商业化的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309095948a459c2e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309095948a459c2e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","02552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163014720","title":"华领医药-B(02552)2月股份变动月报:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1163014720","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163014720?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:40","pubTimestamp":1772703617,"startTime":"0","endTime":"0","summary":"华领医药-B于2026年3月5日发布截至2026年2月28日的股份变动月报。报告显示,公司法定股本仍为2,000,000,000股,每股面值0.001美元,法定股本总额2,000,000美元,与上月无异。期权注销并未导致当月任何实际股份增发。公司确认已遵守香港联合交易所有限公司的上市规则及相关法律规定。截至2026年2月28日,华领医药-B总股本保持稳定,公告由公司秘书袁颖欣签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617520176","title":"每日卖空追踪 | 华领医药-B 03月05日卖空量成交33万股,卖空比例为9.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617520176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617520176?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:30","pubTimestamp":1772699432,"startTime":"0","endTime":"0","summary":"华领医药-B北京时间03月05日,涨7.39%,卖空量成交33万股,较上一交易日减少13.27%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163422a44ef867&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163422a44ef867&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02552","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617123520","title":"华领医药-B03月05日获主力加仓30.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617123520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617123520?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:16","pubTimestamp":1772698563,"startTime":"0","endTime":"0","summary":"03月05日, 华领医药-B股价涨7.39%,报收3.05元,成交金额1100.3万元,换手率0.34%,振幅9.86%,量比0.95。华领医药-B今日主力资金净流入30.9万元,连续3日净流入,上一交易日主力净流入96.6万元。|03月05日主力加仓幅度排名||#|股票简称|主力净额占比|#|PACIFICLEGEND|4.43%|#|亨泰|2.51%|#|立高控股|2.46%|#|...|...|#338|华领医药-B|0.01%|(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305162122a6a5ca95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305162122a6a5ca95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02552","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617122520","title":"华领医药-B盘中涨近10% 核心产品华领片近日在香港获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2617122520","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617122520?lang=zh_cn&edition=full","pubTime":"2026-03-05 15:04","pubTimestamp":1772694249,"startTime":"0","endTime":"0","summary":"华领医药-B(02552)盘中涨近10%,截至发稿,涨6.69%,报3.03港元,成交额1066.1万港元。消息面上,3月3日,华领医药宣布,其全球首创新药葡萄糖激酶激活剂(GKA)多格列艾汀(dorzagliatin)(商品名:MYHOMSIS,华领片)已获香港卫生署批准上市,用于治疗成人2型糖尿病。这一成果标志着华领医药以香港为枢纽,从中国正式进军东南亚及全球市场的战略布局已迈出关键一步。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305151250a6a58274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305151250a6a58274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02552","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616302498","title":"核心产品华领片®于香港获批上市,华领医药-B(02552)开启全球化新征程","url":"https://stock-news.laohu8.com/highlight/detail?id=2616302498","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616302498?lang=zh_cn&edition=full","pubTime":"2026-03-04 10:55","pubTimestamp":1772592900,"startTime":"0","endTime":"0","summary":"3月3日,华领医药-B的全球化布局迎来关键节点。公司宣布,其全球首创新药葡萄糖激酶激活剂多格列艾汀已获香港卫生署批准上市,用于治疗成人2型糖尿病。从香港本地市场来看,多格列艾汀的上市有望为当地糖尿病诊疗注入新活力。整体而言,华领片于香港获批上市,是华领医药从“中国原研”向“全球创新”深化的关键一步。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"核心产品华领片®于香港获批上市,华领医药-B(02552)开启全球化新征程","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02552","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616601813","title":"华领医药-B(02552):多格列艾汀在香港获批上市,用于治疗成人2型糖尿病","url":"https://stock-news.laohu8.com/highlight/detail?id=2616601813","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616601813?lang=zh_cn&edition=full","pubTime":"2026-03-03 08:04","pubTimestamp":1772496279,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华领医药-B 发布公告,其全球首创新药葡萄糖激酶启动剂 多格列艾汀 已获中国香港特别行政区政府卫生署药物办公室批准上市,用于治疗成人2型糖尿病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华领医药-B(02552):多格列艾汀在香港获批上市,用于治疗成人2型糖尿病","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02552","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616252361","title":"每日卖空追踪 | 华领医药-B 03月02日卖空量成交21.75万股,卖空比例为7.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616252361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616252361?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:30","pubTimestamp":1772440234,"startTime":"0","endTime":"0","summary":"华领医药-B北京时间03月02日,跌5.52%,卖空量成交21.75万股,较上一交易日减少20.77%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163452a730c7a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163452a730c7a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02552","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.huamedicine.com","stockEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":0.1774},{"period":"3month","weight":0.1128},{"period":"6month","weight":-0.1205},{"period":"1year","weight":0.901},{"period":"ytd","weight":0.1851}],"compareEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":0.0191},{"period":"3month","weight":-0.0098},{"period":"6month","weight":-0.0151},{"period":"1year","weight":0.2864},{"period":"ytd","weight":0.0102}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华领医药是一家主要从事用于治疗2型糖尿病的口服新药的开发及商业化的投资控股公司。该公司还从事华堂宁产品的商业化。该公司的主要产品管线Dorzagliatin或HMS5552是一种葡萄糖激酶激活剂或GKA,旨在通过恢复2型糖尿病患者的血糖稳态平衡来控制糖尿病的渐进性退行性特性。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.004737},{"month":2,"riseRate":0.5,"avgChangeRate":-0.007017},{"month":3,"riseRate":0.375,"avgChangeRate":-0.030115},{"month":4,"riseRate":0.375,"avgChangeRate":-0.038839},{"month":5,"riseRate":0.571429,"avgChangeRate":0.088992},{"month":6,"riseRate":0.571429,"avgChangeRate":0.052547},{"month":7,"riseRate":0.428571,"avgChangeRate":0.032661},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.045943},{"month":9,"riseRate":0.714286,"avgChangeRate":0.034598},{"month":10,"riseRate":0.125,"avgChangeRate":-0.101466},{"month":11,"riseRate":0.5,"avgChangeRate":0.071213},{"month":12,"riseRate":0.625,"avgChangeRate":0.032299}],"exchange":"SEHK","name":"华领医药-B","nameEN":"HUA MEDICINE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华领医药-B(02552)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华领医药-B(02552)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华领医药-B,02552,华领医药-B股票,华领医药-B股票老虎,华领医药-B股票老虎国际,华领医药-B行情,华领医药-B股票行情,华领医药-B股价,华领医药-B股市,华领医药-B股票价格,华领医药-B股票交易,华领医药-B股票购买,华领医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华领医药-B(02552)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华领医药-B(02552)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}